Cerebral Cavernous Malformation 2 (CCM2) Peptide
CCM2
Reactivity: Human
Host: Synthetic
BP, BI
Catalog No. ABIN5685765
Quick Overview for Cerebral Cavernous Malformation 2 (CCM2) Peptide (ABIN5685765)
Target
CCM2
(Cerebral Cavernous Malformation 2 (CCM2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Characteristics
- CCM2 peptide corresponds to 13 amino acids of CCM2.
-
-
Cerebral Cavernous Malformation 2 (CCM2) peptide
CCM2 Reactivity: Human, Cow, Dog, Mouse, Rat Host: Synthetic BP, Imm
-
-
Application Notes
- CCM2 Peptide is used for blocking the activity of CCM2 antibody . The CCM2 antibody ships at 0.5 mg/mL and the CCM2 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- CCM2 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
-
Gene ID
- 83605
-
NCBI Accession
- NP_001025006, NP_113631
-
OMIM
- 71067341
-
UniProt
- Q9BSQ5
Target
-
You are here:
